Oxidative Stress-Induced alterations in PPAR-7 and associated mitochondrial destabilization contribute to kidney cell apoptosis

American Journal of Physiology - Renal Physiology

Volumn 307, Issue 7, 2014, Pages F814-F822

  Small, David M ^a   Morais, Christudas ^a   Coombes, Jeff S ^a   Bennett, Nigel C ^a,b   Johnson, David W ^a,c   Gobe, Glenda C ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c PRINCESS ALEXANDRA HOSPITAL   (Australia)

Author keywords

Mitochondria; Oxidative stress; Peroxisome proliferator activated receptor 7; Thiozolidinediones

Indexed keywords

ADENOSINE TRIPHOSPHATE; PARKIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PIOGLITAZONE; PROTEIN P62; ROSIGLITAZONE; SUPEROXIDE; TROGLITAZONE;

APOPTOSIS; ARTICLE; CELL PROTECTION; CELL ULTRASTRUCTURE; CELL VIABILITY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; ELECTRON MICROSCOPY; FLUORESCENCE ANALYSIS; HUMAN; HUMAN CELL; KIDNEY CELL; KIDNEY EPITHELIUM; KIDNEY PROXIMAL TUBULE; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; MITOPHAGY; MITOSIS; OXIDATIVE STRESS; PROTEIN PHOSPHORYLATION; SELECTIVE AUTOPHAGY; WESTERN BLOTTING; CELL LINE; METABOLISM; MITOCHONDRIAL DYNAMICS; UROTHELIUM;

APOPTOSIS; CELL LINE; HUMANS; KIDNEY TUBULES, PROXIMAL; MITOCHONDRIAL TURNOVER; OXIDATIVE STRESS; PPAR GAMMA; UROTHELIUM;

EID: 84907482119     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00205.2014     Document Type: Article

References (51)

1. Ahmadian M, Suh JM, Hah N, Liddle C, Atkins AR, Downes M, Evans RM. PPAR-y signaling and metabolism: the good, the bad and the future. Nat Med 19: 557-566, 2013.
2. Bjorkoy G, Lamark T, Brech A, Outzen H, Perander M, Overvatn A, Stenmark H, Johansen T. p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death. J Cell Biol 171: 603-614, 2005.
3. Cai Q, Zakaria HM, Simone A, Sheng ZH. Spatial parkin translocation and degradation of damaged mitochondria via mitophagy in live cortical neurons. Curr Biol 22: 545-552, 2012.
4. Calkin AC, Giunti S, Jandeleit-Dahm KA, Allen TJ, Cooper ME, Thomas MC. PPAR-a and -y agonists attenuate diabetic kidney disease in the apolipoprotein E knockout mouse. Nephrol Dial Transplant 21: 2399-2405, 2006.
5. Camp HS, Tafuri SR. Regulation of peroxisome proliferator-activated receptor gamma activity by mitogen-activated protein kinase. J Biol Chem 272: 10811-10816, 1997.
6. Chiang MC, Cheng YC, Lin KH, Yen CH. PPAR-y regulates the mitochondrial dysfunction in human neural stem cells with tumor necrosis factor a. Neuroscience 229: 118-129, 2013.
7. Choi JH, Banks AS, Estall JL, Kajimura S, Bostrom P, Laznik D, Ruas JL, Chalmers MJ, Kamenecka TM, Bluher M, Griffin PR, Spiegelman BM. Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPAR-y by Cdk5. Nature 466: 451–456, 2010.
8. Dounousi E, Papavasiliou E, Makedou A, Ioannou K, Katododis K, Tselepis A, Siamopoulos K, Tsakiris D. Oxidative stress is progressively enhanced with advancing stages of chronic kidney disease. Nephrol Dial Transplant 21: 385-385, 2006.
9. Egan DF, Shackelford DB, Mihaylova MM, Gelino S, Kohnz RA, Mair W, Vasquez DS, Joshi A, Gwinn DM, Taylor R, Asara JM, Fitzpatrick J, Dillin A, Viollet B, Kundu M, Hansen M, Shaw RJ.Phosphorylation of ULK1 (hATG1) by AMP-activated protein kinase connects energy sensing to mitophagy. Science 331: 456-461, 2011.
10. Fuenzalida K, Quintanilla R, Ramos P, Piderit D, Fuentealba RA, Martinez G, Inestrosa NC, Bronfman M. Peroxisome proliferator-activated receptor -y up-regulates the Bcl-2 anti-apoptotic protein in neurons and induces mitochondrial stabilization and protection against oxidative stress and apoptosis. J Biol Chem 282: 37006-37015, 2007.
11. Fujisawa K, Nishikawa T, Kukidome D, Imoto K, Yamashiro T, Motoshima H, Matsumura T, Araki E. TZDs reduce mitochondrial ROS production and enhance mitochondrial biogenesis. Biochem Biophys Res Commun 379: 43-48, 2009.
12. Funk JA, Odejinmi S, Schnellmann RG. SRT1720 induces mitochondrial biogenesis and rescues mitochondrial function after oxidant injury in renal proximal tubule cells. J Pharmacol Exp Ther 333: 593-601, 2010.
13. Geisler S, Holmstrom KM, Skujat D, Fiesel FC, Rothfuss OC, Kahle PJ, Springer W. PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1. Nat Cell Biol 12: 119-131, 2010.
14. Gobe G. Identification of apoptosis in kidney tissue sections. Methods Mol Biol 466: 175-192, 2009.
15. Gomes P, Simao S, Silva E, Pinto V, Amaral JS, Afonso J, Serrao MP, Pinho MJ, Soares-da-Silva P. Aging increases oxidative stress and renal expression of oxidant and antioxidant enzymes that are associated with an increased trend in systolic blood pressure. Oxid Med Cell Longev 2: 138-145, 2009.
16. Granata S, Zaza G, Simone S, Villani G, Latorre D, Pontrelli P, Carella M, Schena FP, Grandaliano G, Pertosa G. Mitochondrial dysregulation and oxidative stress in patients with chronic kidney disease. BMC Genomics 10: 388, 2009.
17. Guan Y, Breyer MD. Peroxisome proliferator-activated receptors (PPARs): novel therapeutic targets in renal disease. Kidney Int 60: 14-30, 2001.
18. Guan Y, Zhang Y, Breyer MD. The role of PPARs in the transcriptional control of cellular processes. Drug News Perspect 15: 147-154, 2002.
19. Hall AM, Crawford C, Unwin RJ, Duchen MR, Peppiatt-Wildman CM. Multiphoton imaging of the functioning kidney. J Am Soc Nephrol 22: 1297-1304, 2011.
20. Hall AM, Unwin RJ, Parker N, Duchen MR. Multiphoton imaging reveals differences in mitochondrial function between nephron segments. J Am Soc Nephrol 20: 1293-1302, 2009.
21. Hock MB, Kralli A. Transcriptional control of mitochondrial biogenesis and function. Annu Rev Physiol 71: 177-203, 2009.
22. Hondares E, Mora O, Yubero P, Rodriguez dlCM, Iglesias R, Giralt M, Villarroya F. Thiazolidinediones and rexinoids induce peroxisome proliferator-activated receptor-coactivator (PGC)-1a gene transcription: an autoregulatory loop controls PGC-1a expression in adipocytes via peroxisome proliferator-activated receptor--/ coactivation. Endocrinology 147: 2829-2838, 2006.
23. Hu E, Kim JB, Sarraf P, Spiegelman BM. Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPAR-y. Science 274: 2100-2103, 1996.
24. Ishihara M, Urushido M, Hamada K, Matsumoto T, Shimamura Y, Ogata K, Inoue K, Taniguchi Y, Horino T, Fujieda M, Fujimoto S, Terada Y. Sestrin-2 and BNIP3 regulate autophagy and mitophagy in renal tubular cells in acute kidney injury. Am J Physiol Renal Physiol 305: F495-F509, 2013.
25. Jiang D, Chen K, Lu X, Gao HJ, Qin ZH, Lin F. Exercise ameliorates the detrimental effect of chloroquine on skeletal muscles in mice via restoring autophagy flux. Acta Pharmacol Sin 35: 135-142, 2014.
26. Kanjanabuch T, Ma LJ, Chen J, Pozzi A, Guan Y, Mundel P, Fogo AB. PPAR-7 agonist protects podocytes from injury. Kidney Int 71: 1232-1239, 2007.
27. Kincaid-Smith P, Fairley KF, Farish S, Best JD, Proietto J. Reduction of proteinuria by rosiglitazone in non-diabetic renal disease. Nephrology (Carlton) 13: 58-62, 2008.
28. Komatsu M, Kageyama S, Ichimura Y. p62/SQSTM1/A170: physiology and pathology. Pharmacol Res 66: 457–462, 2012.
29. Komatsu M, Kurokawa H, Waguri S, Taguchi K, Kobayashi A, Ichimura Y, Sou YS, Ueno I, Sakamoto A, Tong KI, Kim M, Nishito Y, Iemura S, Natsume T, Ueno T, Kominami E, Motohashi H, Tanaka K, Yamamoto M. The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1. Nat Cell Biol 12: 213-223, 2010.
30. Komatsu M, Waguri S, Koike M, Sou YS, Ueno T, Hara T, Mizushima N, Iwata J, Ezaki J, Murata S, Hamazaki J, Nishito Y, Iemura S, Natsume T, Yanagawa T, Uwayama J, Warabi E, Yoshida H, Ishii T, Kobayashi A, Yamamoto M, Yue Z, Uchiyama Y, Kominami E, Tanaka K. Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice. Cell 131: 1149-1163, 2007.
31. Leff T. AMP-activated protein kinase regulates gene expression by direct phosphorylation of nuclear proteins. Biochem Soc Trans 31: 224-227, 2003.
32. Lepenies J, Hewison M, Stewart PM, Quinkler M. Renal PPAR-y mRNA expression increases with impairment of renal function in patients with chronic kidney disease. Nephrology (Carlton) 15: 683-691, 2010.
33. Martin A, Perez-Giron JV, Hernanz R, Palacios R, Briones AM, Fortuno A, Zalba G, Salaices M, Alonso MJ. Peroxisome proliferator-activated receptor--/ activation reduces cyclooxygenase-2 expression in vascular smooth muscle cells from hypertensive rats by interfering with oxidative stress. J Hypertens 30: 315-326, 2012.
34. Miglio G, Rosa AC, Rattazzi L, Grange C, Camussi G, Fantozzi R. Protective effects of peroxisome proliferator-activated receptor agonists on human podocytes: proposed mechanisms of action. Br J Pharmacol 167: 641-653, 2012.
35. Narendra D, Tanaka A, Suen DF, Youle RJ. Parkin is recruited selectively to impaired mitochondria and promotes their autophagy. J Cell Biol 183: 795-803, 2008.
36. Nath KA. Tubulointerstitial changes as a major determinant in the progression of renal damage. Am J Kidney Dis 20: 1-17, 1992.
37. Niizuma S, Nakamura S, Ishibashi-Ueda H, Yoshihara F, Kawano Y. Kidney function and histological damage in autopsy subjects with myocardial infarction. Ren Fail 33: 847-852, 2011.
38. Portilla D, Dai G, McClure T, Bates L, Kurten R, Megyesi J, Price P, Li S. Alterations of PPARa and its coactivator PGC-1 in cisplatin-induced acute renal failure. Kidney Int 62: 1208-1218, 2002.
39. Rasbach KA, Schnellmann RG. Signaling of mitochondrial biogenesis following oxidant injury. J Biol Chem 282: 2355-2362, 2007.
40. Shao D, Liu J, Ni J, Wang Z, Shen Y, Zhou L, Huang Y, Wang J, Xue H, Zhang W, Lu L. Suppression of XBP1S mediates high glucose-induced oxidative stress and extracellular matrix synthesis in renal mes-angial cell and kidney of diabetic rats. PLOS ONE 8: e56124, 2013.
41. Small DM, Bennett NC, Roy S, Gabrielli BG, Johnson DW, Gobe GC. Oxidative stress and cell senescence combine to cause maximal renal tubular epithelial cell dysfunction and loss in an in vitro model of kidney disease. Nephron Exp Nephrol 122: 123-130, 2012.
42. Stanton RC. Oxidative stress and diabetic kidney disease. CurrDiab Rep 11: 330-336, 2011.
43. Wang X, Dai Y, Ding Z, Khaidakov M, Mercanti F, Mehta JL. Regulation of autophagy and apoptosis in response to angiotensin II in HL-1 cardiomyocytes. Biochem Biophys Res Commun 440: 696-700, 2013.
44. Weinberg JM. Mitochondrial biogenesis in kidney disease. J Am Soc Nephrol 22: 431–436, 2011.
45. Whiteside C, Wang H, Xia L, Munk S, Goldberg HJ, Fantus IG. Rosiglitazone prevents high glucose-induced vascular endothelial growth factor and collagen IV expression in cultured mesangial cells. Exp Diabetes Res 2009: 910783, 2009.
46. Wu JS, Lin TN, Wu KK. Rosiglitazone and PPAR-7 overexpression protect mitochondrial membrane potential and prevent apoptosis by up-regulating anti-apoptotic Bcl-2 family proteins. J Cell Physiol 220: 58-71, 2009.
47. Xu Y, Ruan S, Wu X, Chen H, Zheng K, Fu B. Autophagy and apoptosis in tubular cells following unilateral ureteral obstruction are associated with mitochondrial oxidative stress. Int J Mol Med 31: 628-636, 2013.
48. Yang HC, Deleuze S, Zuo Y, Potthoff SA, Ma LJ, Fogo AB. The PPAR-y agonist pioglitazone ameliorates aging-related progressive renal injury. J Am Soc Nephrol 20: 2380-2388, 2009.
49. Yang HC, Ma LJ, Ma J, Fogo AB. Peroxisome proliferator-activated receptor--/ agonist is protective in podocyte injury-associated sclerosis. Kidney Int 69: 1756-1764, 2006.
50. Zhan M, Brooks C, Liu F, Sun L, Dong Z. Mitochondrial dynamics: regulatory mechanisms and emerging role in renal pathophysiology. Kidney Int 83: 568-581, 2013.
51. Zhang B, Berger J, Zhou G, Elbrecht A, Biswas S, White-Car-rington S, Szalkowski D, Moller DE. Insulin- and mitogen-activated protein kinase-mediated phosphorylation and activation of peroxisome proliferator-activated receptor gamma. J Biol Chem 271: 31771–31774, 1996.